Research on HIV infection and how the virus behaves. Covers viral persistence, prevention policy, adolescent consent, and how HIV infects cells.
A recent analysis of ACTG 076 data found that the risk of perinatal transmission of HIV can occur even when a woman has little or no detectable virus in her blood. Offering AZT therapy to all pregnant HIV-infected women is crucial, regardless of their stage of disease.
Emory University researchers identified a subpopulation of HIV-infected infants with a thymic-defect profile, characterized by low CD4+ and CD8+ T cell counts. These high-risk infants were found to develop AIDS symptoms sooner and have increased mortality rates compared to those without the profile.
The study results provided conclusive evidence that antiretroviral therapy can reduce the risk of death in people with intermediate-stage HIV disease. Combination therapies showed promise in slowing disease progression and reducing mortality rates, particularly in patients without prior antiretroviral treatment.
A recent study found that patients with vancomycin-resistant enterococcal infections acquired them in hospitals, resulting in high mortality rates and increased treatment costs. The study highlights the need for proper antibiotic utilization and collaboration among healthcare professionals to prevent antibiotic resistance.
A study conducted by the University of Washington found that HIV transmission can occur even among individuals with few sexual partners, and that oral sex is a common route of transmission among gay men. Despite warnings from health experts, unprotected oral sex may not be as safe as previously thought.
Researchers are exploring two protocols to tackle AIDS: Protocol 1 focuses on reconstituting immune systems through thymus tissue transplants and boosting T-cells. Protocol 2 involves high-dose chemotherapy, radiation, and blood stem cell transplantation to treat cancer and restore immunity in patients with double jeopardy.